Influence of preoperative intravitreal injection of Ranibizumab on perioperative VRS parameters in patients with PDR

Influence of preoperative intravitreal injection of Ranibizumab on perioperative VRS parameters in patients with PDR

AIM: To discuss the effects of preoperative vitreous cavity injection of ranibizumab on 25G minimally invasive vitreoretinal surgery(VRS)in patients with proliferative diabetic retinopathy(PDR).<p>METHODS: From February 2013 to December 2015, 74 patients with PDR received VRS(82 eyes)were retr...

Full description

Bibliographic Details
Main Authors:	Jun-Xia Lu, Su-Hua Li, Hua Tian
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2017-08-01
Series:	Guoji Yanke Zazhi
Subjects:	proliferative diabetic retinopathy vitreoretinal surgery ranibizumab vitreous resuscitation
Online Access:	http://ies.ijo.cn/cn_publish/2017/8/201708044.pdf

Similar Items

Expression and its clinical significance of RBP4 in vitreous in patients with proliferative diabetic retinopathy
by: Tian-Yue Cao, et al.
Published: (2018-05-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

Early versus Late Pars Plana Vitrectomy in Vitreous Hemorrhage: A Systematic Review
by: Filippo Confalonieri, et al.
Published: (2023-10-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

A Case of Syphilitic Uveitis in Which Vitreous Surgery Was Useful for the Diagnosis and Treatment
by: Takatoshi Kobayashi, et al.
Published: (2017-01-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Vitreous Substitutes from Bench to the Operating Room in a Translational Approach: Review and Future Endeavors in Vitreoretinal Surgery
by: Filippo Confalonieri, et al.
Published: (2023-02-01)

Phacoemulsification of primary cataract by the second stage after vitreoretinal surgery of PDR patients.
by: Karina Igorevna Konovalova, et al.
Published: (2021-01-01)

Reasons for the Late Presentation of Diabetic Retinopathy in Saudi Arabia: A Survey of Patients Who Presented with Advanced Proliferative Diabetic Retinopathy to a Tertiary Eye Hospital
by: Al-Shehri AM, et al.
Published: (2022-12-01)

Efficacy of 25G pars plana vitrectomy with Conbercept intravitreal injection at the end of surgery for early proliferative diabetic retinopathy with vitreous hemorrhage
by: Su Zhang, et al.
Published: (2023-03-01)

Results of research of brain-derived neurotrophic factor level (BDNF) in the vitreous body of patients with proliferative diabetic retinopathy
by: A.A. Putienko, et al.
Published: (2016-02-01)

Causes of vitreous haemorrhage in a tertiary hospital in southern Nigeria
by: Otabor-Olubor OJ, et al.
Published: (2021-01-01)

Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy
by: Qiao-Yun Gong, et al.
Published: (2022-11-01)

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
by: Yuzhi Ding, et al.
Published: (2023-03-01)

Comparison of intravitreal injection of Ranibizumab versus Conbercept in the treatment of retinopathy of prematurity
by: Chen Juan, et al.
Published: (2024-05-01)

A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy
by: Chang-Yu Qiu, et al.
Published: (2022-12-01)

Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy
by: Ze-Yu Liang, et al.
Published: (2022-10-01)

Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)

Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook
by: Sarah R. Weber, et al.
Published: (2021-05-01)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
by: Albert L Lin, et al.
Published: (2020-10-01)

Vitreous properties in patients with diabetes mellitus and its relationship with proliferative diabetic retinopathy
by: Yi Gong, et al.
Published: (2023-09-01)

Macro-microscopic study of posterior vitreous detachment variants in an ex vivo experiment
by: N. M. Kislitsyna, et al.
Published: (2021-01-01)

Risk Factors for Recurrent Vitreous Hemorrhage in Type 2 Diabetes Mellitus Patients after Posterior Vitrectomy
by: Marc Baget-Bernaldiz, et al.
Published: (2023-04-01)

Clinical Efficacy of Preoperative and Intraoperative Intravitreal Ranibizumab as Adjuvant Therapy of Ahmed Glaucoma Valve Implantation Combined with Vitrectomy in the Management of Neovascular Glaucoma with Diabetic Vitreous Hemorrhage
by: Shuang Gao, et al.
Published: (2023-12-01)

The treatment results in patients with diabetic proliferative retinopathy who underwent vitrectomy after a ranibizumab injection. Vitrectomy after ranibizumab in diabetes
by: A. Shein, et al.
Published: (2018-04-01)

Proteomic study of vitreous in proliferative diabetic retinopathy patients after treatment with aflibercept: a quantitative analysis based on 4D label-free technique
by: Ting-Ting Feng, et al.
Published: (2024-04-01)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
by: Irene Andrés-Blasco, et al.
Published: (2023-05-01)

Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage [Corrigendum]
by: Guo H, et al.
Published: (2023-10-01)

Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage
by: Guo H, et al.
Published: (2023-09-01)

Frequency of vitreoretinal adhesion in retinal vessels in patients with axial myopia of different age groups
by: O. V. Kolenko, et al.
Published: (2020-10-01)

Ex Vivo Visualization of Distribution of Intravitreal Injections in the Porcine Vitreous and Hydrogels Simulating the Vitreous
by: Tobias Auel, et al.
Published: (2023-02-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
by: Irini Chatziralli, et al.
Published: (2021-07-01)

Effect of Adjunctive Intravitreal Conbercept Injection at the End of 25G Vitrectomy on Severe Proliferative Diabetic Retinopathy: 6-Month Outcomes of a Randomised Controlled Trial
by: Houshuo Li, et al.
Published: (2023-02-01)

Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial
by: Jinfeng Qu, et al.
Published: (2023-01-01)

Surgical management of spontaneous vitreous hemorrhage, presumably of rhegmatogenous origin
by: D. O. Shkvorchenko, et al.
Published: (2022-04-01)

Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy—A Review
by: Maciej Gawęcki, et al.
Published: (2023-12-01)

Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
by: Siying Li, et al.
Published: (2022-12-01)

Late postoperative vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy—observation versus intervention
by: Anand S Brar, et al.
Published: (2024-01-01)

Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
by: Yusuke Kameda, et al.
Published: (2021-11-01)